Brian M. Stuglik
CIK: 0001716328
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (14 total)
- Jun 12, 2026PBYI
PUMA BIOTECHNOLOGY, INC.
Sale(S)Direct8.1K shares at avg. $7.20$58K - Jun 11, 2026PBYI
PUMA BIOTECHNOLOGY, INC.
Award(A)Direct27K shares- - May 21, 2026VSTM
Verastem, Inc.
Award(A)Direct36K shares- - Dec 16, 2025VSTM
Verastem, Inc.
Sale(S)Direct592 shares at avg. $9.14$5K - Sep 16, 2025VSTM
Verastem, Inc.
Sale(S)Direct587 shares at avg. $9.99$6K - Jun 16, 2025VSTM
Verastem, Inc.
Sale(S)Direct594 shares at avg. $5.65$3K - Jun 13, 2025PBYI
PUMA BIOTECHNOLOGY, INC.
Sale(S)Direct8.1K shares at avg. $3.39$27K - Jun 11, 2025PBYI
PUMA BIOTECHNOLOGY, INC.
Award(A)Direct27K shares- - May 22, 2025VSTM
Verastem, Inc.
Award(A)Direct8.3K shares- - Mar 17, 2025VSTM
Verastem, Inc.
Sale(S)Direct593 shares at avg. $6.95$4K - Dec 19, 2024VSTM
Verastem, Inc.
Sale(S)Direct334 shares at avg. $4.37$1K - Dec 16, 2024VSTM
Verastem, Inc.
Sale(S)Direct595 shares at avg. $4.54$3K - Sep 19, 2024VSTM
Verastem, Inc.
Sale(S)Direct336 shares at avg. $2.79$937.44 - Sep 16, 2024VSTM
Verastem, Inc.
Sale(S)Direct600 shares at avg. $2.80$2K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 12, 2026 |  PBYI PUMA BIOTECHNOLOGY, INC. | Sale(S) | 8,100 | $7.20 | $58,311 | Direct |
| Jun 11, 2026 | PBYI PUMA BIOTECHNOLOGY, INC. | Award(A) | 27,000 | - | $0 | Direct |
| May 21, 2026 |  VSTM Verastem, Inc. | Award(A) | 36,000 | - | $0 | Direct |
| Dec 16, 2025 | VSTM Verastem, Inc. | Sale(S) | 592 | $9.14 | $5,411 | Direct |
| Sep 16, 2025 | VSTM Verastem, Inc. | Sale(S) | 587 | $9.99 | $5,864 | Direct |
| Jun 16, 2025 | VSTM Verastem, Inc. | Sale(S) | 594 | $5.65 | $3,356 | Direct |
| Jun 13, 2025 | PBYI PUMA BIOTECHNOLOGY, INC. | Sale(S) | 8,100 | $3.39 | $27,459 | Direct |
| Jun 11, 2025 | PBYI PUMA BIOTECHNOLOGY, INC. | Award(A) | 27,000 | - | - | Direct |
| May 22, 2025 | VSTM Verastem, Inc. | Award(A) | 8,333 | - | - | Direct |
| Mar 17, 2025 | VSTM Verastem, Inc. | Sale(S) | 593 | $6.95 | $4,121 | Direct |
| Dec 19, 2024 | VSTM Verastem, Inc. | Sale(S) | 334 | $4.37 | $1,460 | Direct |
| Dec 16, 2024 | VSTM Verastem, Inc. | Sale(S) | 595 | $4.54 | $2,701 | Direct |
| Sep 19, 2024 | VSTM Verastem, Inc. | Sale(S) | 336 | $2.79 | $937 | Direct |
| Sep 16, 2024 | VSTM Verastem, Inc. | Sale(S) | 600 | $2.80 | $1,680 | Direct |
1-14 of 14 transactions
About Stuglik Brian M
Stuglik Brian M (SEC CIK 0001716328) files insider reports with the SEC as Director of PUMA BIOTECHNOLOGY, INC. (PBYI) and Director of Verastem, Inc. (VSTM).
Signal8 holds 12 ownership filings by Stuglik Brian M, all Form 4s, filed between Sep 18, 2024 and Jun 15, 2026. Those filings report 14 transactions, from Sep 16, 2024 to Jun 12, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Stuglik Brian M's filings is in LOS ANGELES, CA.
Recent filings by Stuglik Brian M
- Jun 12, 2026: Open-market sale of PBYI shares (Form 4, code S).
- Jun 11, 2026: Grant or award of PBYI shares (Form 4, code A).
- May 21, 2026: Grant or award of VSTM shares (Form 4, code A).
- Dec 16, 2025: Open-market sale of VSTM shares (Form 4, code S).
- Sep 16, 2025: Open-market sale of VSTM shares (Form 4, code S).
Other insiders filing for PUMA BIOTECHNOLOGY, INC. (PBYI)
- WILSON TROY EDWARD, Director
- Cesano Alessandra, Director
- AUERBACH ALAN H, President and CEO
- HUNT DOUGLAS M
- NOUGUES MAXIMO F, Chief Financial Officer
- Senderowicz Adrian, Director